MENU
CLOSE
Home
News
2019 Announcements
2019 Announcements
Filters:
Category
Latest
2016 Announcements
2017 Announcements
2018 Announcements
2019 Announcements
2020 Announcements
2021 Announcements
2022 Announcements
2023 Announcements
2024 Announcements
2025 Announcements
Clinical
Corporate
Financial
News
Newsletter
Pages
Presentation
Recruitment
Regulatory
Stories
SCENESSE® registration dossier submitted in Australia
2019 Announcements
23.12.2019
Notice of Change of Interests of Substantial Holder
2019 Announcements
10.12.2019
Change of Director’s Interest Notice
2019 Announcements
09.12.2019
Lapse and Forfeit of Unlisted Conditional Performance Rights
2019 Announcements
06.12.2019
Changes of Director’s Interest Notice
2019 Announcements
05.12.2019
Appendix 3B
2019 Announcements
05.12.2019
Changes in Composition to Committeess
2019 Announcements
05.12.2019
CEO Letter
2019 Announcements
02.12.2019
Appendix 3X
2019 Announcements
26.11.2019
CLINUVEL Appoints Non-Executive Director
2019 Announcements
26.11.2019
Chair’s Address to the Annual General Meeting
2019 Announcements
20.11.2019
Results of Meeting
2019 Announcements
20.11.2019
Managing Director’s AGM Presentation
2019 Announcements
20.11.2019
.
1
2
3
…
6
›
About
About CLINUVEL
People
Corporate Governance
Photomedicine Foundation
Annual Reports
Pharmaceuticals
Pharmaceutical Development
The Science
Disease Entities
Products
PhotoCosmetics
About PhotoCosmetics
Polychromatic Photoprotection
DNA Repair
Melanogenesis
Investors
Investors Information
ASX Announcements
Analyst Coverage
Media Coverage
Company Snapshot
Financial Summary
Shareholder Information
Investor Enquiry
News
Contact
Store
Go To Top